Brief: Better Therapeutics Completes Exploratory Trial For Fatty Liver Disease And Announces Positive Topline Results

Better Therapeutics

08/12/2022 13:06

Dec 8 (Reuters) - Better Therapeutics Inc  BTTX.O :
    * BETTER THERAPEUTICS COMPLETES EXPLORATORY TRIAL FOR FATTY
LIVER
DISEASE AND ANNOUNCES POSITIVE TOPLINE RESULTS
    * BETTER THERAPEUTICS INC - INTENDS TO APPLY FOR
BREAKTHROUGH
DEVICE DESIGNATION WITH FDA
    * BETTER THERAPEUTICS INC - LIVVITA STUDY MET ITS PRIMARY
ENDPOINT
    * BETTER THERAPEUTICS INC - NO SEVERE ADVERSE EVENTS OR
DEVICE
RELATED ADVERSE EVENTS

Source text for Eikon:  ID:nBw3lSsGda 
Further company coverage:  BTTX.O 
 ((Reuters.Briefs@thomsonreuters.com;))